Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Langley

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
The Economic Record|January 1, 1977
Inter-regional migration and economic opportunity, Australia, 1966-71P C Langley
Clinical Therapeutics|March 25, 1999
The technology of metered-dose inhalers and treatment costs in asthma: a retrospective study of breath actuation versus traditional press-and-breathe inhalersP C Langley
Clinical Therapeutics|March 1, 1995
Therapy evaluation, patient distribution, and cost-outcomes ratiosP C Langley
Clinical Therapeutics|November 1, 1996
Assessing the input costs of disease management programsP C Langley
Clinical Therapeutics|November 1, 1993
The role of pharmacoeconomic guidelines for formulary approval: the Australian experienceP C Langley
Pharmacoeconomics|June 6, 1996
Cost effectiveness and the allocation of therapies in a treating populationP C Langley
Pharmacoeconomics|November 11, 1999
Formulary submission guidelines for Blue Cross and Blue Shield of Colorado and Nevada. Structure, application and manufacturer responsibilitiesP C Langley
The Quality Letter for Healthcare Leaders|August 5, 1997
Lessons from formulary decisionmakingP C Langley
The Annals of Pharmacotherapy|September 1, 1995
Comment: substantiation in pharmacoeconomic evaluationsP C Langley
Clinical Therapeutics|July 1, 1997
Treatment costs, equilibrium, and the allocation of patients to therapy alternativesP C Langley, S K Bhattacharyya
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
The Economic Record|January 1, 1977
Inter-regional migration and economic opportunity, Australia, 1966-71P C Langley
Clinical Therapeutics|March 25, 1999
The technology of metered-dose inhalers and treatment costs in asthma: a retrospective study of breath actuation versus traditional press-and-breathe inhalersP C Langley
Clinical Therapeutics|March 1, 1995
Therapy evaluation, patient distribution, and cost-outcomes ratiosP C Langley
Clinical Therapeutics|November 1, 1996
Assessing the input costs of disease management programsP C Langley
Clinical Therapeutics|November 1, 1993
The role of pharmacoeconomic guidelines for formulary approval: the Australian experienceP C Langley
Pharmacoeconomics|June 6, 1996
Cost effectiveness and the allocation of therapies in a treating populationP C Langley
Pharmacoeconomics|November 11, 1999
Formulary submission guidelines for Blue Cross and Blue Shield of Colorado and Nevada. Structure, application and manufacturer responsibilitiesP C Langley
The Quality Letter for Healthcare Leaders|August 5, 1997
Lessons from formulary decisionmakingP C Langley
The Annals of Pharmacotherapy|September 1, 1995
Comment: substantiation in pharmacoeconomic evaluationsP C Langley
Clinical Therapeutics|July 1, 1997
Treatment costs, equilibrium, and the allocation of patients to therapy alternativesP C Langley, S K Bhattacharyya
Pageof 4